Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Zhejiang Beta Pharma presents new protein kinase inhibitors for cancer

April 26, 2011

KW-2450 suppresses tumor growth in vivo and advances in phase I/II trial in breast cancer

April 26, 2011

New CSF-1-R inhibitor DCC-2909 shows promise to treat bone metastasis

April 26, 2011

Oncolytics Biotech reports interim data from Reolysin trial in metastatic colorectal cancer

April 21, 2011

New inhibitors of hepatocyte growth factor receptor designed

April 21, 2011

Marina Biotech completes enrollment of first cohort in START-FAP trial of CEQ-508

April 21, 2011

University of California presents new bladder cancer-specific ligand peptides

April 21, 2011

CH-5424802 shows promise in ALK-positive tumors and advances in phase I/II trial in NSCLC

April 21, 2011

Celgene begins phase III trials of pomalidomide in multiple myeloma

April 20, 2011

Bristol-Myers Squibb begins phase I study of BMS-906024 in solid tumors

April 20, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...